title: Joint modelling of longitudinal outcome and interval-censored competing risk dropout in a schizophrenia clinical trial.
abstract: The 'Clinical antipsychotic trials in intervention effectiveness' study, was designed to evaluate whether there were significant differences between several antipsychotic medications in effectiveness, tolerability, cost and quality of life of subjects with schizophrenia. Overall, 74 % of patients discontinued the study medication for various reasons before the end of 18 months in phase I of the study. When such a large percentage of study participants fail to complete the study schedule, it is not clear whether the apparent profile in effectiveness reflects genuine changes over time or is influenced by selection bias, with participants with worse (or better) outcome values being more likely to drop out or to discontinue. To assess the effect of dropouts for different reasons on inferences, we construct a joint model for the longitudinal outcome and cause-specific dropouts that allows for interval-censored dropout times. Incorporating the information regarding the cause of dropout improves inferences and provides better understanding of the association between cause-specific dropout and the outcome process. We use simulations to demonstrate the advantages of the joint modelling approach in terms of bias and efficiency.
authors.affiliation: Yale University School of Medicine, New Haven, USA.
authors.forename: Ralitza
authors.initials: R
authors.lastname: Gueorguieva
authors.forename: Robert
authors.initials: R
authors.lastname: Rosenheck
authors.forename: Haiqun
authors.initials: H
authors.lastname: Lin